drugset / Trial / NCT04923269
A Study of LY3532226 in Healthy Participants
RandomizedParallel-groupDouble-blindBasic science
Summary
The main purpose of this study is to evaluate the safety and tolerability of the study drug known as LY3532226 in healthy participants. Blood tests will be performed to check how much LY3532226 gets into the bloodstream and how long it takes the body to eliminate it. This study will last approximately 8 weeks including screening period.
Timeline
- Start
- 2021-06-10
- Primary completion
- 2021-10-28
- Completion
- 2021-10-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Macupatide | Protein / enzyme biologic | — | Subcutaneous |
Indications
No indication recorded.